← Mechanisms of action
Human leukocyte antigen DR beta chain
PROTEIN FAMILYHomo sapiens
Linked proteins
- HLA class II histocompatibility antigen, DRB1-1 beta chain ↗
- HLA class II histocompatibility antigen, DR beta 3 chain (HLA-DRB3) ↗
- HLA class II histocompatibility antigen, DRB1-3 chain ↗
- HLA class II histocompatibility antigen, DRB1-9 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-12 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-10 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-13 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-8 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-16 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-4 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-7 beta chain ↗
- HLA class II histocompatibility antigen, DR beta 5 chain (HLA-DRB5) ↗
- HLA class II histocompatibility antigen, DRB1-15 beta chain (HLA-DRB1) ↗
- HLA class II histocompatibility antigen, DRB1-14 beta chain ↗
- HLA class II histocompatibility antigen, DRB1-11 beta chain ↗
- HLA class II histocompatibility antigen, DR beta 4 chain (HLA-DRB4) ↗
Drugs acting on this target (1)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| apolizumab | Inhibitor | experimental | mAb | Human leukocyte antigen DR beta chain inhibitor |